| Financial Year |
March 31 2023 |
| Monetary Funds |
85,677,575.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,661,300.00 |
| Accounts Receivable |
195,415,372.49 |
| Advances to Suppliers |
23,713,274.70 |
| Other Receivables |
1,066,564.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
158,147,923.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
50,000,000.00 |
| Other Current Assets |
51,541,133.34 |
| Total Current Assets |
595,480,815.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
26,097,838.52 |
| Fixed Assetes |
89,791,491.78 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,637,745.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,478,073.51 |
| Deferred Income Tax Assets |
5,370,224.23 |
| Other Non-Current Assets |
20,000,000.00 |
| Sub-Total of Non-Current Assets |
187,199,190.97 |
| Total Assets |
782,680,006.17 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
41,687,185.61 |
| Accounts Payable |
163,073,196.01 |
| Accounts Received In Advance |
1,757,296.25 |
| Employee Compensation Payable |
6,856.72 |
| Taxes Payable |
4,527,637.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,967,587.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
8,892,493.48 |
| Sub-Total of Current Liabilities |
272,954,019.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,922,600.00 |
| Deferred Income Tax Liabilities |
2,041,087.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,963,687.27 |
| Total Liabilities |
277,917,706.40 |
| Paid-In Capital(Or Share Stock) |
219,120,000.00 |
| Capital Surplus |
202,737,643.80 |
| Surplus Reserve |
26,074,221.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
50,543,033.91 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
504,762,299.77 |
| Owner's Equity（Stockholder's Equity） |
504,762,299.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
782,680,006.17 |
